The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Bilayered Bioengineered Skin Substitute (Apligraf??*): A Review of its Use in the Treatment of Venous Leg Ulcers and Diabetic Foot Ulcers
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ulcer-related medical costs of patients with either VLU or DFU following treatment with Apligraf are lower in comparison with conventional wound care therapy (Harding et al 2000; Schonfeld et al 2000; Curran and Plosker 2002; Fivenson and Scherschun 2003; Redekop et al 2003).”
From A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers (2007) · cites this paper as Curran and Plosker 2002
In the citing paper
“Controlled clinical studies have shown that Apligraf is more effective and economical at healing chronic VLU (Schonfeld et al 2000; Curran and Plosker 2002; Fivenson and Scherschun 2003) and DFU (Veves et al 2001; Redekop et al 2003) than standard wound care therapy alone.”
From A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers (2007) · cites this paper as Curran and Plosker 2002
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The “trap” hypothesis of venous ulceration
Falanga, V., & Eaglstein, W. (1993) · The Lancet · doi:10.1016/0140-6736(93)91085-z · Cited by 330
Research works printed but not linked: 30
- Waymack, 2000, Burns, 26, 609, 10.1016/S0305-4179(00)00017-6 · DOI · Paper page
- Brem, 2001, Dermatol Surg, 27, 915
- Long, 2001, Arch Dermatol, 137, 1660
- Bell, 1991, Toxicol In Vitro, 5, 591, 10.1016/0887-2333(91)90099-Y · DOI
- Bilbo, 1993, J Toxicol Cutaneous Ocul Toxicol, 12, 183, 10.3109/15569529309036259 · DOI
- Nolte, 1994, J Anat, 185, 325
- Navsaria, 1995, Trends Biotech, 13, 91, 10.1016/S0167-7799(00)88913-1 · DOI
- Nemecek, 1999, Toxicol Pathol, 27, 101, 10.1177/019262339902700118 · DOI
- Brain, 1989, BMJ, 298, 917, 10.1136/bmj.298.6678.917 · DOI
- Burt, 1989, BMJ, 298, 915, 10.1136/bmj.298.6678.915 · DOI
- Sabolinski, 1996, Biomaterials, 17, 311, 10.1016/0142-9612(96)85569-4 · DOI
- Kirsner, 1996, Br J Dermatol, 135, 292, 10.1111/j.1365-2133.1996.tb01164.x · DOI
- Kerstein, 2001, Dis Manage Health Outcomes, 9, 651, 10.2165/00115677-200109110-00005 · DOI
- Mathias, 2001, Adv Skin Wound Care, 13, 76
- Harding, 19, BMJ 200 Jan, 324, 160, 10.1136/bmj.324.7330.160 · DOI
- Douglas, 1995, Br J Dermatol, 132, 446, 10.1111/j.1365-2133.1995.tb08681.x · DOI
- Nelzen, 1994, Br J Surg, 81, 182, 10.1002/bjs.1800810206 · DOI
- Oien, 2000, Scand J Prim Health Care, 18, 220, 10.1080/028134300448788 · DOI
- Hansson, 1988, Acta Chir Scand Suppl, 544, 12
- Heit, 2001, J Vasc Surg, 33, 1022, 10.1067/mva.2001.113308 · DOI · Paper page
- Fletcher, 6, BMJ 199 Sep, 315, 576, 10.1136/bmj.315.7108.576 · DOI
- Phillips, 1991, J Am Acad Dermatol, 26, 965, 10.1016/0190-9622(91)70295-D · DOI
- Bello, 2001, Am J Clin Dermatol, 2, 305, 10.2165/00128071-200102050-00005 · DOI
- Leigh, 1987, Br J Dermatol, 117, 591, 10.1111/j.1365-2133.1987.tb07491.x · DOI
- Boyce, 1999, J Burn Care Rehabil, 20, 453, 10.1097/00004630-199920060-00006 · DOI
- Gentzkow, 1996, Diabetes Care, 19, 350, 10.2337/diacare.19.4.350 · DOI
- Purdue, 1997, J Burn Care Rehabil, 18, 52, 10.1097/00004630-199701000-00009 · DOI
- Eisenberg, 1998, Br J Plast Surg, 51, 608, 10.1054/bjps.1998.9997 · DOI
- Ramsey, 1999, Diabetes Care, 22, 382, 10.2337/diacare.22.3.382 · DOI
- Elkeles, 26, BMJ 199 Oct, 303, 1053, 10.1136/bmj.303.6809.1053 · DOI
Cited by
Zaulyanov, L., & Kirsner, R. S. (2007) · Clinical Interventions in Aging · doi:10.2147/ciia.2007.2.1.93 · Cited by 266
Metadata
- Authors
- Curran, M. P., & Plosker, G. L.
- Venue
- BioDrugs
- Published
- 2002
- Volume
- 16
- Issue
- 6
- Pages
- 439-455
- ISSN
- 1173-8804
- Cited by
- 99
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
